SCHEMBL6983222

SCHEMBL6983222

CC1OCC(=O)C1(C)NC(=O)C(CNC(=O)c1ccc(-c2cnns2)cc1)c1ccc(O)cc1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6988884 0.86 CTSS (0.36)
SCHEMBL6987871 0.84 CTSK (0.39)
SCHEMBL6753779 0.83 CTSL (0.37)
SCHEMBL6982132 0.83 TAOK1 (0.36) MAPK8
SCHEMBL6988403 0.83 KMT2A (0.35)
SCHEMBL6989542 0.83 TP53 (0.40)
SCHEMBL6990082 0.82 MAPT (0.41)
SCHEMBL6990056 0.82 OPRM1 (0.37)
SCHEMBL6988433 0.81 TAS1R3 (0.35)
SCHEMBL6988694 0.80 ATM (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1362042-A1 CYCLIC 2-CARBONYLAMINOKETONES AS INHIBITORS OF CRUZIPAIN AND OTHER CYSTEINE PROTEASES Amura Therapeutics Limited (GB) 2003-11-19 EP disclosed
WO-2002057249-A1 CYCLIC 2-CARBONYLAMINOKETONES AS INHIBITORS OF CRUZIPAIN AND OTHER CYSTEINE PROTEASES AMURA THERAPEUTICS LIMITED (GB) 2002-07-25 WO disclosed